Angiomyolipoma
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Angiomyolipoma Classification and external resources | |
| ICD-10 | D30.0 |
|---|---|
| ICD-9 | 223.0 |
| ICD-O: | M8860/0 |
| DiseasesDB | 29496 |
| MeSH | D018207 |
|
WikiDoc Resources for Angiomyolipoma | |
|
Articles | |
|---|---|
|
Most recent articles on Angiomyolipoma Most cited articles on Angiomyolipoma | |
|
Media | |
|
Powerpoint slides on Angiomyolipoma | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Angiomyolipoma at Clinical Trials.gov Trial results on Angiomyolipoma Clinical Trials on Angiomyolipoma at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Angiomyolipoma NICE Guidance on Angiomyolipoma
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Angiomyolipoma Discussion groups on Angiomyolipoma Patient Handouts on Angiomyolipoma Directions to Hospitals Treating Angiomyolipoma Risk calculators and risk factors for Angiomyolipoma
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Angiomyolipoma | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Angiomyolipoma is a benign renal neoplasm previously considered to be a hamartoma or choristoma, but now known to be neoplastic.[1] It is composed of variable amounts of fat, vascular, and smooth muscle elements. The fat density of the tumour on CT has been regarded to be pathognomonic, although there are now case reports of renal cell carcinoma types also possessing macroscopic fat.
The lesion is well demarcated and contains mature elements. It occurs in more than 50% of individuals with tuberous sclerosis, often bilaterally. Angiomyolipomata also occur in 40% of women who have a rare, cystic lung disease called lymphangioleiomyomatosis, or LAM.[2]
Incidence
The incidence is about 0.3-3%. It occurs in more than 50% of individuals with tuberous sclerosis, often bilaterally. It is twice as common in females as in males.
Types
- Isolated Angiomyolipoma (80%)
- Angiomyolipoma is about 4 times more common in women than in men.
- Interestingly, 80% of the cases involve the right kidney.
- Angiomyolipoma associated with tuberous sclerosis (20%).
- Angiomyolipoma occurs in 80% patients with tuberous sclerosis.
- Angiomyolipoma also occurs young women with lymphangiomyomatosis without other stigmata of tuberous sclerosis. Angiomyolipoma and lymphangiomyomatosis are sometimes considered the forme fruste of tuberous sclerosis.
Diagnosis
Demonstration of fat in renal tumor is virtually diagnostic of angiomyolipoma. Most small lesions are asymptomatic and incidental findings on images. The fat density of the tumour on CT is pathognomonic.
Diagnostic Findings
Histopathological Findings
Complications
Complications include hematuria, flank pain, and shock as a result of spontaneous hemorrhage.
References
- ↑ Eble JN. Angiomyolipoma of the kidney. Semin Diagn Pathol 1988;15:21-40
- ↑ McCormack FX (2006). "Lymphangioleiomyomatosis". MedGenMed 8 (1): 15. PMID 16915145.
See also
External links
WikiDoc Research Resources for Angiomyolipoma | |
|---|---|
| Articles on Angiomyolipoma | Most recent articles on Angiomyolipoma • Most cited articles on Angiomyolipoma • Review articles on Angiomyolipoma • Articles on Angiomyolipoma in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Angiomyolipoma | Powerpoint slides on Angiomyolipoma • Images of Angiomyolipoma • Photos of Angiomyolipoma • Podcasts & MP3s on Angiomyolipoma • Videos on Angiomyolipoma |
| Evidence Based Medicine Regarding Angiomyolipoma | Cochrane Collaboration on Angiomyolipoma • Bandolier on Angiomyolipoma • TRIP on Angiomyolipoma |
| Cost Effectiveness of Angiomyolipoma | Cost Effectiveness of Angiomyolipoma |
| Clinical Trials Involving Angiomyolipoma | Ongoing Trials on Angiomyolipoma at Clinical Trials.gov • Trial results on Angiomyolipoma • Clinical Trials on Angiomyolipoma at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Angiomyolipoma | US National Guidelines Clearinghouse on Angiomyolipoma • NICE Guidance on Angiomyolipoma • NHS PRODIGY Guidance • FDA on Angiomyolipoma • CDC on Angiomyolipoma |
| Textbook Information on Angiomyolipoma | Books and Textbook Information on Angiomyolipoma |
| Pharmacology Resources on Angiomyolipoma | Dosing of Angiomyolipoma • Drug interactions with Angiomyolipoma • Side effects of Angiomyolipoma • Allergic reactions to Angiomyolipoma • Overdose information on Angiomyolipoma • Carcinogenicity information on Angiomyolipoma • Angiomyolipoma in pregnancy • Pharmacokinetics of Angiomyolipoma • |
| Genetics, Pharmacogenomics, and Proteinomics of Angiomyolipoma | Genetics of Angiomyolipoma • Pharmacogenomics of Angiomyolipoma • Proteomics of Angiomyolipoma |
| Newstories on Angiomyolipoma | Angiomyolipoma in the news • Be alerted to news on Angiomyolipoma • News trends on Angiomyolipoma |
| Commentary on Angiomyolipoma | Blogs on Angiomyolipoma |
| Patient Resources on Angiomyolipoma | Patient resources on Angiomyolipoma • Discussion groups on Angiomyolipoma • Patient Handouts on Angiomyolipoma • Directions to Hospitals Treating Angiomyolipoma • Risk calculators and risk factors for Angiomyolipoma |
| Healthcare Provider Resources on Angiomyolipoma | Symptoms of Angiomyolipoma • Causes & Risk Factors for Angiomyolipoma • Diagnostic studies for Angiomyolipoma • Treatment of Angiomyolipoma |
| Continuing Medical Education (CME) Programs on Angiomyolipoma | CME Programs on Angiomyolipoma |
| International Resources on Angiomyolipoma | Angiomyolipoma en Espanol • Angiomyolipoma en Francais |
| Business Resources on Angiomyolipoma | Angiomyolipoma in the Marketplace • Patents on Angiomyolipoma |
| Informatics Resources on Angiomyolipoma | List of terms related to Angiomyolipoma |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

